Precision BioSciences, Inc.
DTIL
$5.07
$0.112.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -37.93% | -95.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -37.93% | -95.45% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -37.93% | -95.45% | |||
| SG&A Expenses | 6.51% | 17.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.11% | -13.12% | |||
| Operating Income | 1.06% | 11.00% | |||
| Income Before Tax | -14.37% | -15.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.37% | -15.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.37% | -15.89% | |||
| EBIT | 1.06% | 11.00% | |||
| EBITDA | 1.00% | 10.97% | |||
| EPS Basic | 3.80% | 0.23% | |||
| Normalized Basic EPS | 4.08% | -4.94% | |||
| EPS Diluted | 3.76% | 0.28% | |||
| Normalized Diluted EPS | 4.08% | -4.94% | |||
| Average Basic Shares Outstanding | 18.88% | 16.16% | |||
| Average Diluted Shares Outstanding | 18.88% | 16.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||